Findings of Misconduct in Science, 73084-73085 [2010-29867]

Download as PDF 73084 Federal Register / Vol. 75, No. 228 / Monday, November 29, 2010 / Notices Item No. 4 ..................... Bureau CONSUMER AFFAIRS. AND Subject GOVERNMENTAL The Bureau will present an overview of the Twenty-First Century Communications and Video Accessibility Act, Public Law 111–260, the Commission’s implementation plans, and demonstrate accessibility technologies. The meeting site is fully accessible to people using wheelchairs or other mobility aids. Sign language interpreters, open captioning, and assistive listening devices will be provided on site. Other reasonable accommodations for people with disabilities are available upon request. In your request, include a description of the accommodation you will need and a way we can contact you if we need more information. Last minute requests will be accepted, but may be impossible to fill. Send an e-mail to: fcc504@fcc.gov or call the Consumer & Governmental Affairs Bureau at 202–418–0530 (voice), 202–418–0432 (tty). Additional information concerning this meeting may be obtained from Audrey Spivack or David Fiske, Office of Media Relations, (202) 418–0500; TTY 1–888–835–5322. Audio/Video coverage of the meeting will be broadcast live with open captioning over the Internet from the FCC Live Web page at https://www.fcc.gov/live. For a fee this meeting can be viewed live over George Mason University’s Capitol Connection. The Capitol Connection also will carry the meeting live via the Internet. To purchase these services call (703) 993–3100 or go to https://www.capitolconnection.gmu.edu. Copies of materials adopted at this meeting can be purchased from the FCC’s duplicating contractor, Best Copy and Printing, Inc. (202) 488–5300; Fax (202) 488–5563; TTY (202) 488–5562. These copies are available in paper format and alternative media, including large print/type; digital disk; and audio and video tape. Best Copy and Printing, Inc. may be reached by e-mail at FCC@BCPIWEB.com. and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than December 9, 2010. A. Federal Reserve Bank of San Francisco (Kenneth Binning, Vice President, Applications and Enforcement) 101 Market Street, San Francisco, California 94105–1579: 1. Franklin Resources, Inc., San Mateo, California; to acquire additional voting shares of First Chicago Bancorp, and thereby indirectly acquire voting shares of First Chicago Bank & Trust, both of Chicago, Illinois. Marlene H. Dortch, Secretary, Federal Communications Commission. [FR Doc. 2010–30169 Filed 11–24–10; 4:15 pm] Board of Governors of the Federal Reserve System, November 24, 2010. Robert deV. Frierson, Deputy Secretary of the Board. BILLING CODE P [FR Doc. 2010–30050 Filed 11–26–10; 8:45 am] BILLING CODE 6210–01–P mstockstill on DSKH9S0YB1PROD with NOTICES FEDERAL RESERVE SYSTEM DEPARTMENT OF HEALTH AND HUMAN SERVICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes VerDate Mar<15>2010 17:57 Nov 26, 2010 Jkt 223001 Office of the Secretary Findings of Misconduct in Science Office of the Secretary, HHS. Notice. AGENCY: ACTION: PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case: Bengu Sezen, Ph.D., Columbia University: Based on the findings of an investigation by Columbia University (CU) and additional analysis conducted by the Office of Research Integrity (ORI) during its oversight review, ORI found that Bengu Sezen, former graduate student, Department of Chemistry, CU, engaged in misconduct in science in research funded by National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH), grant R01 GM60326. Specifically, ORI made twenty-one (21) findings of scientific misconduct against Dr. Sezen based on evidence that she knowingly and intentionally falsified and fabricated, and in one instance plagiarized, data reported in three (3) papers 1 and her doctoral thesis. The following administrative actions have been implemented for a period of five (5) years, beginning on November 4, 2010: (1) Dr. Sezen is debarred from eligibility for any contracting or subcontracting with any agency of the United States Government and from eligibility or involvement in nonprocurement programs of the United States Government, referred to as ‘‘covered transactions,’’ pursuant to HHS’ Implementation of OMB Guidelines to Agencies on Governmentwide Debarment and Suspension (2 CFR 376 et seq.); and (2) Dr. Sezen is prohibited from serving in any advisory capacity to the U.S. Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. SUMMARY: 1 Sezen, B., Franz, R., & Sames, D. ‘‘C–C bond formation via C–H bond activations: Catalytic arylation and alkenation of alkane segments.’’ J. Am. Chem. Soc. 124:13372–13373, 2002. Retracted in J. Am. Chem. Soc. 128:8364, 2006. Sezen, B. & Sames, D. ‘‘Oxidative C-arylation of free (NH)—heterocycles via direct (sp3) C–H bond functionalization.’’ J. Am. Chem. Soc. 126:13244– 13246, 2004. Retracted in J. Am. Chem. Soc. 128:3102, 2006. Sezen, B. & Sames, D. ‘‘Selective and catalytic arylation of N-phenylpryrrolidine: sp3 C–H bond functionalization in the absence of a directing group.’’ J. Am. Chem. Soc. 127:5284–5285, 2005. Retracted in J. Am. Chem Soc. 128:3102, 2006. E:\FR\FM\29NON1.SGM 29NON1 Federal Register / Vol. 75, No. 228 / Monday, November 29, 2010 / Notices FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. John Dahlberg, Director, Division of Investigative Oversight, Office of Research Integrity. [FR Doc. 2010–29867 Filed 11–26–10; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Toxicology Program (NTP): Office of Liaison, Policy, and Review; Availability of Draft NTP Technical Reports; Request for Comments; Announcement of a Panel Meeting to Peer Review Draft NTP Technical Reports National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH). ACTION: Availability of Draft Reports; Request for Comments; and Announcement of a Meeting. AGENCY: The NTP announces the availability of draft NTP Technical Reports (TRs; available at https:// ntp.niehs.nih.gov/go/36051) that will be peer-reviewed by an NTP Technical Reports Peer Review Panel at a meeting on January 26, 2011. The meeting is open to the public with time scheduled for oral public comment. The NTP also invites written comments on the draft reports (see ‘‘Request for Comments’’ below). Summary minutes from the peer review will be posted on the NTP Web site following the meeting. DATES: The meeting to review the draft NTP TRs will be held on January 26, 2011. The draft NTP TRs will be available for public comment by December 8, 2010. The deadline to submit written comments is January 12, 2011, and the deadline for preregistration to attend the meeting and/ or provide oral comments at the meeting is January 19, 2011. ADDRESSES: The meeting will be held at the Rodbell Auditorium, Rall Building, NIEHS, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709. Public comments and any other correspondence on the draft TRs should be sent to Dr. Lori White, NIEHS, P.O. Box 12233, MD K2–03, Research Triangle Park, NC 27709, FAX: (919) 541–0295, or whiteld@niehs.nih.gov. Courier address: 530 Davis Drive, Room 2136, Morrisville, NC 27560. Persons needing interpreting services in order to mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:57 Nov 26, 2010 Jkt 223001 attend should contact (301) 402–8180 (voice) or (301) 435–1908 (TTY). Requests should be made at least seven business days in advance of the meeting. FOR FURTHER INFORMATION CONTACT: Dr. Lori White, NTP Designated Federal Officer, (919) 541–9834, whiteld@niehs.nih.gov. SUPPLEMENTARY INFORMATION: Preliminary Agenda Topics and Availability of Meeting Materials The agenda topic is the peer review of the findings and conclusions of draft NTP TRs of toxicology and carcinogenicity studies. The preliminary agenda listing the draft reports and electronic files (PDF) of the draft reports should be posted on the NTP Web site by December 8, 2010. Any additional information, when available, will be posted on the NTP Web site (https:// ntp.niehs.nih.gov/go/36051) or may be requested in hardcopy from the Designated Federal Officer (see ADDRESSES above). Following the meeting, summary minutes will be prepared and made available on the NTP Web site. Information about the NTP testing program is found at https://ntp.niehs.nih.gov/go/test. Attendance and Registration The meeting is scheduled for January 26, 2011, from 8:30 a.m. EST to adjournment and is open to the public with attendance limited only by the space available. Individuals who plan to attend are encouraged to register online at the NTP Web site (https:// ntp.niehs.nih.gov/go/36051) by January 19, 2011, to facilitate access to the NIEHS campus. A photo ID is required to access the NIEHS campus. The NTP is making plans to videocast the meeting through the Internet at https:// www.niehs.nih.gov/news/video/live. Registered attendees are encouraged to access the meeting page to stay abreast of the most current information regarding the meeting. Request for Comments The NTP invites written comments on the draft reports, which should be received by January 12, 2011, to enable review by the panel and NTP staff prior to the meeting. Persons submitting written comments should include their name, affiliation, mailing address, phone, e-mail, and sponsoring organization (if any) with the document. Written comments received in response to this notice will be posted on the NTP Web site, and the submitter will be identified by name, affiliation, and/or sponsoring organization. PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 73085 Public input at this meeting is also invited, and time is set aside for the presentation of oral comments on the draft reports. In addition to in-person oral comments at the meeting at the NIEHS, public comments can be presented by teleconference line. There will be 50 lines for this call; availability will be on a first-come, first-served basis. The available lines will be open from 8:00 AM until adjournment on January 26, although public comments will be received only during the formal public comment periods indicated on the preliminary agenda. Each organization is allowed one time slot per draft report. At least 7 minutes will be allotted to each speaker, and if time permits, may be extended to 10 minutes at the discretion of the chair. Persons wishing to make an oral presentation are asked to notify Dr. Lori White via online registration at https://ntp.niehs.nih.gov/ go/166, phone, or e-mail (see ADDRESSES above) by January 19, 2011, and if possible, to send a copy of the statement or talking points at that time. Written statements can supplement and may expand the oral presentation. Registration for oral comments will also be available at the meeting, although time allowed for presentation by on-site registrants may be less than that for preregistered speakers and will be determined by the number of persons who register on-site. Background Information on NTP Peer Review Panels NTP panels are technical, scientific advisory bodies established on an ‘‘as needed’’ basis to provide independent scientific peer review and advise the NTP on agents of public health concern, new/revised toxicological test methods, or other issues. Previously, a subcommittee of the NTP Board of Scientific Counselors provided peer review of draft NTP Technical Reports. The subcommittee has been discontinued and peer review of the draft reports will now be conducted by peer review panels. These panels help ensure transparent, unbiased, and scientifically rigorous input to the program for its use in making credible decisions about human hazard, setting research and testing priorities, and providing information to regulatory agencies about alternative methods for toxicity screening. The NTP welcomes nominations of scientific experts for upcoming panels. Scientists interested in serving on an NTP panel should provide a current curriculum vita to Dr. Lori White (see ADDRESSES). The authority for NTP panels is provided by 42 U.S.C. 217a; section 222 of the Public Health Service (PHS) Act, as amended. E:\FR\FM\29NON1.SGM 29NON1

Agencies

[Federal Register Volume 75, Number 228 (Monday, November 29, 2010)]
[Notices]
[Pages 73084-73085]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-29867]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Misconduct in Science

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has taken final action in the following case:
    Bengu Sezen, Ph.D., Columbia University: Based on the findings of 
an investigation by Columbia University (CU) and additional analysis 
conducted by the Office of Research Integrity (ORI) during its 
oversight review, ORI found that Bengu Sezen, former graduate student, 
Department of Chemistry, CU, engaged in misconduct in science in 
research funded by National Institute of General Medical Sciences 
(NIGMS), National Institutes of Health (NIH), grant R01 GM60326.
    Specifically, ORI made twenty-one (21) findings of scientific 
misconduct against Dr. Sezen based on evidence that she knowingly and 
intentionally falsified and fabricated, and in one instance 
plagiarized, data reported in three (3) papers \1\ and her doctoral 
thesis.
---------------------------------------------------------------------------

    \1\ Sezen, B., Franz, R., & Sames, D. ``C-C bond formation via 
C-H bond activations: Catalytic arylation and alkenation of alkane 
segments.'' J. Am. Chem. Soc. 124:13372-13373, 2002. Retracted in J. 
Am. Chem. Soc. 128:8364, 2006.
    Sezen, B. & Sames, D. ``Oxidative C-arylation of free (NH)--
heterocycles via direct (sp\3\) C-H bond functionalization.'' J. Am. 
Chem. Soc. 126:13244-13246, 2004. Retracted in J. Am. Chem. Soc. 
128:3102, 2006.
    Sezen, B. & Sames, D. ``Selective and catalytic arylation of N-
phenylpryrrolidine: sp\3\ C-H bond functionalization in the absence 
of a directing group.'' J. Am. Chem. Soc. 127:5284-5285, 2005. 
Retracted in J. Am. Chem Soc. 128:3102, 2006.
---------------------------------------------------------------------------

    The following administrative actions have been implemented for a 
period of five (5) years, beginning on November 4, 2010:
    (1) Dr. Sezen is debarred from eligibility for any contracting or 
subcontracting with any agency of the United States Government and from 
eligibility or involvement in nonprocurement programs of the United 
States Government, referred to as ``covered transactions,'' pursuant to 
HHS' Implementation of OMB Guidelines to Agencies on Governmentwide 
Debarment and Suspension (2 CFR 376 et seq.); and
    (2) Dr. Sezen is prohibited from serving in any advisory capacity 
to the U.S. Public Health Service (PHS), including but not limited to 
service on any PHS advisory committee, board, and/or peer review 
committee, or as a consultant.

[[Page 73085]]


FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

John Dahlberg,
Director, Division of Investigative Oversight, Office of Research 
Integrity.
[FR Doc. 2010-29867 Filed 11-26-10; 8:45 am]
BILLING CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.